Serratia marcescens keratitis: Strain-specific corneal pathogenesis in rabbits

Current Eye Research

Volumn 19, Issue 6, 1999, Pages 525-532

  Hume, Emma B H ^a   Conerly, Lisa L ^a   Moreau, Judy M ^a   Cannon, Bennetta M ^a   Engel, Lee S ^a   Stroman, David W ^b   Hill, James M ^a,c   O'Callaghan, Richard J ^a,c  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

^b ALCON RESEARCH LTD   (United States)

^c LSU EYE CENTER   (United States)

Author keywords

Animal model; Corneal ulcer; Keratitis; Serratia marcescens; Virulence

Indexed keywords

PROTEINASE;

ABSCESS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GROWTH; BACTERIAL METABOLISM; BIOTYPOLOGY; CELL MOTILITY; CONJUNCTIVA DISEASE; CORNEA DISEASE; CORNEA STROMA; EYE INFLAMMATION; IRITIS; KERATITIS; KINETICS; NONHUMAN; PRIORITY JOURNAL; RABBIT; RIBOTYPING; SERRATIA MARCESCENS; SLIT LAMP;

EID: 0033381953     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1076/ceyr.19.6.525.5283     Document Type: Article

References (30)

1. Yu VL. Serratia marcescens: historical perspective and clinical review. N Engl J Med. 1979;300:887-893.
2. Von Graevenitz A. Human disease due to Serratia. In: Von Graevenitz A, Rubin SJ. The Genus Serratia, Boca Raton, FL: CRC Press; 1980:67-186.
3. Allen SD, Conger KB. Serratia marcescens infection of the urinary tract: A nosocomial infection. J Urol. 1969;101:621-623.
4. Graber CD, Higgins IS, Davis JS. Seldom encountered agents of bacterial meningitis. JAMA. 1965;192:956-960.
5. Lancaster LJ. Role of Serratia species in urinary tract infections. Arch Intern Med. 1962;109:536-539.
6. Shedden WI. Meningitis due to Serratia marcescens. Arch Dis Child. 1963;38:97.
7. Wilfert JN, Barrett FF, Kass EH. Bacteremia due to Serratia marcescens. N Engl J Med. 1968;279:286-289.
8. Atlee WE, Burns RP, Oden M. Serratia marcescens keratoconjunctivitis. Am J Ophthalmol. 1970;70:31-33.
9. Bigger JR, Meltzer G, Mandell A, Burde RM. Serratia marcescens endophthalmitis. Am J Ophthalmol. 1971;72: 1102-1105.
10. Cooper R, Constable I. Infective keratitis in soft contact lens wearers. Br J Ophthalmol. 1977;61:250-254.
11. Lazachek GW, Boyle GL, Schwartz AL, Leopold IH. Serratia marcescens, an ocular pathogen: new considerations. Arch Ophthalmol. 1971;86:599-603.
12. Cohen EJ, Laibson PR, Arensten J, Clemons C. Corneal ulcers associated with cosmetic extended wear soft contact lenses. Ophthalmol. 1987;94:109-114.
13. Levine M, Serdarevic O, Mahar M, Chen S. Microbial trends and fluoroquinolone resistance in contact lens related microbial keratitis. Invest Ophthalmol Vis Sci. 1996:37 (suppl 3):S876.
14. Holden BA, La Hood D, Grant T, Newton-Howes J, Baleriola-Lucas C, Willcox MDP, Sweeney DF. Gramnegative bacteria can induce contact lens related acute red eye (CLARE) responses. CLAO J. 1996;22:47-52.
15. Grant T, Terry R, Holden BA. Extended wear of hydrogel lenses: clinical problems and their management. In: Harris M. Problems in Optometry, Philadelphia, PA: JB Lippincott; 1990:599-622.
16. Hume EBH, Willcox MDP, Sweeney DF, Holden BA. An examination of the clonal variants of Serratia marcescens that infect the eye during contact lens wear. J Med Microbiol. 1996;45:127-132.
17. Shah AS, McNamara NA, Fleiszig SMJ. Pilot study of corneal surface bacterial flora isolated from ocular irrigation samples. Invest Ophthalmol Vis Sci. 1999:40 (suppl 4):S261.
18. Van Buskirk AL, Assil KK, Bahadur GG, Shulman DG, Wapner FJ, Graves AL. A pilot, multi-center evaluation of 0.5% levofloxacin ophthalmic solution: a new ophthalmic fluoroquinolone. Invest Ophthalmol Vis Sci. 1999:40 (suppl 4):S689.
19. Lyerly D, Gray L, Kreger AS. Characterization of rabbit corneal damage produced by Serratia keratitis and by a Serratia protease. Infect Immun. 1981;33:927-932.
20. Kreger AS, Griffin OK. Cornea-damaging proteases. Invest Ophthalmol. 1975;14:190-197.
21. Molla A, Matsumura Y, Yamamoto T, Okamura R, Maeda H. Pathogenic capacity of proteases from Serratia marcescens and Pseudomonas aeruginosa and their suppression by chicken egg white ovomacroglobulin. Infect Immun. 1987;55:2509-2517.
22. Miyagawa S, Matsumoto K, Kamata R, Okamura R, Maeda H. Spreading of Serratia marcescens in experimental keratitis and growth suppression by chicken egg white ovomacroglobulin. Jpn J Ophthalmol. 1991;35:402-410.
23. Kamata R, Matsumoto K, Okamura R, Yamamoto T, Maeda H. The serratial 56K protease as a major pathogenic factor in serratial keratitis. Clinical and experimental study. Ophthalmol. 1985;92:1452-1459.
24. Maeda H, Molla A. Pathogenic potential proteases. Clin Chim Acta. 1989;185:357-368.
25. Twining SS, Kirschner SE, Mahnke LA, Frank DA. Effect of Pseudomonas aeruginosa elastase, alkaline protease, and exotoxin A on corneal proteinases and proteins. Invest Ophthalmol Vis Sci. 1993;34:2699-2712.
26. Matsumoto K, Shams N, Hanninen L, Kenyon K. Proteolytic activation of corneal matrix metalloproteinase by Pseudomonas aeruginosa elastase. Curr Eye Res. 1992;11:1105-1109.
27. Hobden JA, Engel LS, Callegan MC, Hill JM, Gebhardt BM, O'Callaghan RJ. Pseudomonas aeruginosa keratitis in leukopenic rabbits. Curr Eye Res. 1993;12:461-467.
28. SAS Institute Inc. SAS Users Guide: Statistics, version 5. SAS Institute, Cary, NC. 1985
29. Rootman DS, Hobden JA, Jantzen J, Gonzales JR, O'Callaghan RJ, Hill JM. Iontophoresis of tobramycin for the treatment of experimental Pseudomonas keratitis in the rabbit. Arch Ophthalmol. 1988; 106:262-265.
30. Bernstein HN, Maddox YT. Corneal pathogenicity of Serratia marcescetis in the rabbit. Trans Am Acad Ophthalmol Otolaryngol. 1973;77:432-440.